Stratification of inflammatory bowel disease outpatients by disease activity and risk of complications to guide out-of-hospital monitoring: a patient-centred quality improvement project
Year: 2019
BMJ Open Qual
Surgery versus infliximab for Crohn’s disease: should there be a change in clinical practice?
Year: 2020
Lancet Gatroenterol Hepatol
Ethnic differences in inflammatory bowel disease: Results from the United Kingdom inception cohort epidemiology study
Year: 2019
World J Gastroenterol
A Narrative Systematic Review and Categorisation of Outcomes in Inflammatory Bowel Disease to Inform a Core Outcome Set for Real-world Evidence
Year: 2022
Published by: Journal of Crohn’s and Colitis
Authors: Wong, C van Oostrom, J Bossuyt, P Pittet, V Hanzel, J Samaan, M Tripathi, M Czuber-Dochan, W Burisch, J Leone, S Saldana, R Baert, F Kopylov, U Jaghult, S Adamina, M Gecse, K Arebi, N
Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives
Year: 2022
Published by: Lancet Gastroenterology and Hepatology
Authors: Papamichael, Konstantinos Afif, Waqqas Drobne, David Dubinsky, Marla C. Ferrante, Marc Irving, Peter M. Kamperidis, Nikolaos Kobayashi, Taku Kotze, Paulo G. Lambert, Jo Noor, Nurulamin M. Roblin, Xavier Roda, Giulia Vande Casteele, Niels Yarur, Andres J. Arebi, Naila Danese, Silvio Paul, Stephane Sandborn, William J. Vermeire, Severine Cheifetz, Adam S. Peyrin-Biroulet, Laurent
Validation and Update of the Lemann Index to Measure Cumulative Structural Bowel Damage in Crohn’s Disease
Year: 2022
Published by: Gastroenterology
Authors: ariente, B Torres, J Burisch, J Arebi, N Barberio, B Duricova, D Ellul, P Goldis, A Kaimakliotis, I Katsanos, K Krznaric, Z McNamara, D Pedersen, N Sebastian, S Azahaf, M Weimers, P Lung, P Lacognata, C Horak, M Christodoulou, D Domislovic, V Murphy, I Lambert, J Ungaro, R Colombel, JF